Oncolytics Days Sales Outstanding vs Capex To Depreciation Analysis

ONC Stock  CAD 1.26  0.01  0.79%   
Oncolytics Biotech financial indicator trend analysis is much more than just breaking down Oncolytics Biotech prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Oncolytics Biotech is a good investment. Please check the relationship between Oncolytics Biotech Days Sales Outstanding and its Capex To Depreciation accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncolytics Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Oncolytics Stock, please use our How to Invest in Oncolytics Biotech guide.

Days Sales Outstanding vs Capex To Depreciation

Days Sales Outstanding vs Capex To Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Oncolytics Biotech Days Sales Outstanding account and Capex To Depreciation. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Oncolytics Biotech's Days Sales Outstanding and Capex To Depreciation is 0.96. Overlapping area represents the amount of variation of Days Sales Outstanding that can explain the historical movement of Capex To Depreciation in the same time period over historical financial statements of Oncolytics Biotech, assuming nothing else is changed. The correlation between historical values of Oncolytics Biotech's Days Sales Outstanding and Capex To Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Days Sales Outstanding of Oncolytics Biotech are associated (or correlated) with its Capex To Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Depreciation has no effect on the direction of Days Sales Outstanding i.e., Oncolytics Biotech's Days Sales Outstanding and Capex To Depreciation go up and down completely randomly.

Correlation Coefficient

0.96
Relationship DirectionPositive 
Relationship StrengthVery Strong

Days Sales Outstanding

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.
Most indicators from Oncolytics Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Oncolytics Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncolytics Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Oncolytics Stock, please use our How to Invest in Oncolytics Biotech guide.At this time, Oncolytics Biotech's Selling General Administrative is very stable compared to the past year. As of the 4th of December 2024, Enterprise Value is likely to grow to about 118 M, while Tax Provision is likely to drop about 82.9 K.
 2021 2022 2023 2024 (projected)
Net Interest Income98.6K528K1.3M1.4M
Interest Income19.9K528K1.3M1.8M

Oncolytics Biotech fundamental ratios Correlations

0.30.010.90.74-0.84-0.62-0.120.84-0.130.98-0.150.70.460.730.630.320.651.0-0.480.45-0.06-0.49-0.030.040.65
0.30.370.240.58-0.33-0.290.420.46-0.70.330.23-0.12-0.03-0.10.230.320.050.36-0.720.24-0.5-0.67-0.74-0.170.19
0.010.37-0.30.290.02-0.150.550.0-0.39-0.030.34-0.110.09-0.030.210.710.110.03-0.420.23-0.15-0.41-0.320.6-0.01
0.90.24-0.30.51-0.78-0.33-0.070.82-0.040.94-0.330.480.120.470.34-0.10.410.9-0.30.24-0.15-0.25-0.03-0.230.42
0.740.580.290.51-0.58-0.75-0.170.63-0.230.70.040.590.590.620.710.640.630.76-0.610.69-0.05-0.63-0.290.160.77
-0.84-0.330.02-0.78-0.580.460.09-0.950.35-0.860.26-0.54-0.31-0.55-0.47-0.13-0.68-0.840.44-0.060.290.41-0.12-0.03-0.41
-0.62-0.29-0.15-0.33-0.750.460.34-0.390.35-0.55-0.11-0.84-0.81-0.84-0.98-0.6-0.8-0.620.7-0.42-0.050.790.010.01-0.93
-0.120.420.55-0.07-0.170.090.34-0.03-0.48-0.040.04-0.55-0.63-0.55-0.24-0.05-0.35-0.08-0.33-0.22-0.51-0.2-0.49-0.09-0.52
0.840.460.00.820.63-0.95-0.39-0.03-0.340.87-0.220.410.230.430.360.180.520.86-0.430.12-0.24-0.39-0.050.020.42
-0.13-0.7-0.39-0.04-0.230.350.35-0.48-0.34-0.18-0.140.070.050.08-0.34-0.19-0.19-0.180.840.350.480.780.450.22-0.07
0.980.33-0.030.940.7-0.86-0.55-0.040.87-0.18-0.290.620.340.630.560.210.60.99-0.490.35-0.13-0.47-0.06-0.040.57
-0.150.230.34-0.330.040.26-0.110.04-0.22-0.14-0.29-0.10.240.030.050.43-0.12-0.14-0.130.180.09-0.28-0.240.130.08
0.7-0.12-0.110.480.59-0.54-0.84-0.550.410.070.62-0.10.810.980.860.390.890.67-0.310.420.13-0.40.430.080.86
0.46-0.030.090.120.59-0.31-0.81-0.630.230.050.340.240.810.870.750.710.680.44-0.280.510.41-0.450.210.280.83
0.73-0.1-0.030.470.62-0.55-0.84-0.550.430.080.630.030.980.870.840.50.850.7-0.310.470.24-0.440.360.180.86
0.630.230.210.340.71-0.47-0.98-0.240.36-0.340.560.050.860.750.840.570.860.62-0.710.39-0.04-0.770.080.030.87
0.320.320.71-0.10.64-0.13-0.6-0.050.18-0.190.210.430.390.710.50.570.40.33-0.450.560.25-0.56-0.210.570.59
0.650.050.110.410.63-0.68-0.8-0.350.52-0.190.6-0.120.890.680.850.860.40.63-0.440.25-0.2-0.490.440.160.72
1.00.360.030.90.76-0.84-0.62-0.080.86-0.180.99-0.140.670.440.70.620.330.63-0.520.43-0.08-0.53-0.080.020.65
-0.48-0.72-0.42-0.3-0.610.440.7-0.33-0.430.84-0.49-0.13-0.31-0.28-0.31-0.71-0.45-0.44-0.52-0.130.320.970.510.17-0.48
0.450.240.230.240.69-0.06-0.42-0.220.120.350.350.180.420.510.470.390.560.250.43-0.130.2-0.19-0.250.320.54
-0.06-0.5-0.15-0.15-0.050.29-0.05-0.51-0.240.48-0.130.090.130.410.24-0.040.25-0.2-0.080.320.20.20.00.230.22
-0.49-0.67-0.41-0.25-0.630.410.79-0.2-0.390.78-0.47-0.28-0.4-0.45-0.44-0.77-0.56-0.49-0.530.97-0.190.20.450.13-0.59
-0.03-0.74-0.32-0.03-0.29-0.120.01-0.49-0.050.45-0.06-0.240.430.210.360.08-0.210.44-0.080.51-0.250.00.450.180.06
0.04-0.170.6-0.230.16-0.030.01-0.090.020.22-0.040.130.080.280.180.030.570.160.020.170.320.230.130.180.01
0.650.19-0.010.420.77-0.41-0.93-0.520.42-0.070.570.080.860.830.860.870.590.720.65-0.480.540.22-0.590.060.01
Click cells to compare fundamentals

Oncolytics Biotech Account Relationship Matchups

Oncolytics Biotech fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets19.7M34.3M45.9M37.3M38.8M30.5M
Total Current Liabilities12.9M2.7M2.7M3.9M4.2M3.9M
Total Stockholder Equity(107.9K)24.8M36.1M26.5M27.6M17.8M
Property Plant And Equipment Net727.5K609.1K976.3K652K647K460.6K
Net Debt(13.6M)(30.8M)(40.6M)(11.3M)(34.5M)(32.8M)
Retained Earnings(344.6M)(367.1M)(393.4M)(418.3M)(446.0M)(423.7M)
Accounts Payable3.2M1.8K594K2.3M1.1M1.0M
Cash14.1M31.2M41.3M11.7M34.9M19.4M
Non Current Assets Total727.5K609.1K976.3K1.7M647K614.7K
Cash And Short Term Investments14.1M31.2M41.3M32.1M34.9M26.6M
Net Receivables2.1M89.7K866.1K521K15K14.3K
Common Stock Shares Outstanding22.1M40.3M53.5M58.0M67.6M71.0M
Liabilities And Stockholders Equity19.7M34.3M45.9M37.3M38.8M30.5M
Non Current Liabilities Total6.9M6.9M7.1M6.9M7.0M7.4M
Other Current Assets1.5M2.4M2.8M3.0M3.2M3.4M
Other Stockholder Equity33.0M31.0M34.2M40.1M42.1M42.9M
Total Liab19.8M9.6M9.8M10.8M11.3M6.0M
Property Plant And Equipment Gross727.5K609.1K976.3K652K1.3M1.4M
Total Current Assets18.9M33.7M44.9M35.7M38.2M28.0M
Accumulated Other Comprehensive Income464.1K400.2K387.7K662K544K516.8K
Short Term Investments13.1M30.4M1.4M20.5M3.4M3.2M
Short Term Debt339.8K248.9K294K216K133K126.4K
Other Current Liab12.5M2.5M1.8M1.5M3.0M3.2M
Common Stock311.1M356.8M391.3M404.0M430.9M310.7M
Common Stock Total Equity271.7M285.2M311.1M356.8M410.3M294.9M
Net Tangible Assets(107.9K)24.8M36.1M26.5M30.5M19.0M
Property Plant Equipment727.5K609.1K976.3K652K749.8K610.4K
Capital Surpluse33.0M34.6M37.8M40.1M46.1M35.9M
Long Term Debt Total166.4K153.2K361.1K157K180.6K131.6K
Cash And Equivalents1.1M858.0K1.4M11.7M13.4M14.1M
Current Deferred Revenue(3.2K)(1.8K)(594K)(1.1M)(973.8K)(925.1K)
Net Invested Capital(107.9K)24.8M36.1M26.5M27.6M20.3M
Net Working Capital6.1M31.0M42.2M31.7M33.9M26.6M
Capital Stock311.1M356.8M391.3M404.0M430.9M399.6M

Pair Trading with Oncolytics Biotech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Oncolytics Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncolytics Biotech will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Oncolytics Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Oncolytics Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Oncolytics Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Oncolytics Biotech to buy it.
The correlation of Oncolytics Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Oncolytics Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Oncolytics Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Oncolytics Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Oncolytics Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oncolytics Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oncolytics Biotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oncolytics Biotech Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncolytics Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Oncolytics Stock, please use our How to Invest in Oncolytics Biotech guide.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Please note, there is a significant difference between Oncolytics Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncolytics Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oncolytics Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.